Please ensure Javascript is enabled for purposes of website accessibility

Why LifeMD Stock Is Getting Crushed Today

By Prosper Junior Bakiny - Apr 14, 2021 at 4:16PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Investors ran for the hills following the release of a short-seller report.

What happened?

Shares of healthcare services provider LifeMD (LFMD 1.47%) are plunging on Wednesday and were down by 22.3% as of 3:45 p.m. EDT. The company did not report any news, but these losses are a result of a short-seller report issued by investigative research firm Culper Research. 

So what 

In its report, Culper Research makes a series of claims concerning LifeMD, its executives, and its operations which, if true, could be devastating to the healthcare company and its shareholders. For instance, Culper Research alleges that LifeMD presents misleading information regarding its network of doctors and even uses unlicensed professionals "to dispense OTC medication."

Further, Culper Research thinks LifeMD is engaged in fraudulent and illegal activities that are similar to those of Redwood Scientific, a company that faced severe legal penalties at the hands of the U.S. Federal Trade Commission (FTC) back in 2018.

Road sign that says risk ahead.

Image source: Getty Images.

These activities include "unlawful autoshipping, abusive telemarketing, and false claims of its products." Culper Research also notes that some of LifeMD's current executives were implicated in the Redwood scandal, either as employees of the company directly involved in these crimes or as major shareholders. If these claims prove accurate, LifeMD could face the wrath of lawmakers and regulators.

Now what

What should investors make of the allegations brought forth by Culper Research? It's important to remember that there are two sides to every story. As incriminating as Culper Research's report looks, LifeMD could well have ready and convincing rebuttals to these accusations. However, LifeMD's shares will likely be highly volatile now that this report is out there, and I'd think twice about initiating a position in this healthcare stock anytime soon. 

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

LifeMD, Inc. Stock Quote
LifeMD, Inc.
LFMD
$2.07 (1.47%) $0.03

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
316%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/03/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.